Detalhe da pesquisa
1.
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 389(24): 2256-2266, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870955
2.
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 385(13): 1196-1206, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551229
3.
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Cancer
; 127(6): 894-904, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231866
4.
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.
Br J Cancer
; 125(4): 528-533, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050255
5.
Sorafenib for Advanced and Refractory Desmoid Tumors.
N Engl J Med
; 379(25): 2417-2428, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575484
6.
Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care.
J Natl Compr Canc Netw
; 19(2): 122-125, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545684
7.
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma.
Cancer
; 126(1): 105-111, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31509242
8.
Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.
Mol Cell Proteomics
; 17(3): 495-515, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242380
9.
Clinical outcomes and toxicities of pazopanib administered orally in crushed form: Case reports and review of the literature.
J Oncol Pharm Pract
; 26(1): 232-235, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30961437
10.
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma.
Br J Cancer
; 121(5): 417-420, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31353364
11.
Ipilimumab-induced hypophysitis, a single academic center experience.
Pituitary
; 22(5): 488-496, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31327112
12.
Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy.
Eur J Cancer Care (Engl)
; 28(2): e12973, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511450
13.
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
Lancet Oncol
; 19(3): 416-426, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370992
14.
Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
BMC Cancer
; 18(1): 413, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29649990
15.
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
BMC Cancer
; 18(1): 225, 2018 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29486723
16.
Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.
J Surg Oncol
; 117(7): 1479-1486, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633281
17.
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
Cancer
; 123(23): 4640-4647, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832986
18.
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Cancer
; 123(1): 90-97, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696380
19.
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Gynecol Oncol
; 146(3): 531-537, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28651804
20.
Ultraviolet camera-aided sunscreen application in children: Demonstration of efficacy and receptivity.
J Am Acad Dermatol
; 86(6): 1390-1392, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34062214